Certification: Kin Meds publishes a LegitScript certification on its own pages. Where it ships: The site doesn't say which states it serves. Last checked: July 2026, against Kin Meds's own pages. Published price: Kin Meds publishes a figure for semaglutide and tirzepatide — the qualifiers are in "What does Kin Meds cost?" below. What it sells: Brand-name medication as well as compounded, injectable and oral routes. Licensing & trust: 57/100 on the scored dimension of that name — one of the six in our published methodology. Proceed with care: an FDA warning letter to this company is on the public record. It is a disclosure rather than a disqualification — the letter is linked above, and it is worth reading before you decide.

C68/100

Desk Score

Ranked #203

Kin Meds

Q: What does Kin Meds cost?

Semaglutide: $149/mo (brand Wegovy). That is the FDA-approved brand product at $149 a month, which is a different medicine from compounded semaglutide at a different price. Because that figure carries a condition, it is held out of our "cheapest" rankings and out of the median we compute for semaglutide — only flat month-to-month rates compete there. Tirzepatide: $149/mo (brand Zepbound). That is the FDA-approved brand product at $149 a month, which is a different medicine from compounded tirzepatide at a different price. Because that figure carries a condition, it is held out of our "cheapest" rankings and out of the median we compute for tirzepatide — only flat month-to-month rates compete there. All figures as published on Kin Meds's own site and read in July 2026. Prices change — confirm before you order.

Kin Meds is a LegitScript-verified telehealth platform offering both compounded GLP-1s.

Desk Score 68/100 (C) · Verified July 2026

Visit Kin Meds ↗Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way.

Is Kin Meds legit?

Only what Kin Meds publishes and what we could check ourselves — nothing inferred. See the methodology.

FDAWarning letter issued to Kin Meds in February 2026. See the FDA warning-letter database.

Certification: Kin Meds publishes a LegitScript certification on its own pages.
Where it ships: The site doesn't say which states it serves.
Last checked: July 2026, against Kin Meds's own pages.
Published price: Kin Meds publishes a figure for semaglutide and tirzepatide — the qualifiers are in "What does Kin Meds cost?" below.
What it sells: Brand-name medication as well as compounded, injectable and oral routes.
Licensing & trust: 57/100 on the scored dimension of that name — one of the six in our published methodology.

Proceed with care: an FDA warning letter to this company is on the public record. It is a disclosure rather than a disqualification — the letter is linked above, and it is worth reading before you decide.

What does Kin Meds cost?

Each figure exactly as Kin Meds publishes it, with the condition attached to it spelled out.

Semaglutide

$149/mo (brand Wegovy)

That is the FDA-approved brand product at $149 a month, which is a different medicine from compounded semaglutide at a different price.

Because that figure carries a condition, it is held out of our "cheapest" rankings and out of the median we compute for semaglutide — only flat month-to-month rates compete there.

Tirzepatide

$149/mo (brand Zepbound)

That is the FDA-approved brand product at $149 a month, which is a different medicine from compounded tirzepatide at a different price.

Because that figure carries a condition, it is held out of our "cheapest" rankings and out of the median we compute for tirzepatide — only flat month-to-month rates compete there.

All figures as published on Kin Meds's own site and read in July 2026. Prices change — confirm before you order.

Semaglutide: $149/mobrand-name
Tirzepatide: $149/mobrand-name
Coverage: Not listed on Kin Meds's site (checked July 2026)
Brand-name: Yes
Verification: Prices as published on Kin Meds's site — verified july 2026. Each figure's full condition is in “What does Kin Meds cost?” below.

Line Kin Meds up against its closest alternatives. Or go one-on-one: Kin Meds vs CoreAge Rx.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency78/100

State access24/100

Molecule range97/100

Onboarding speed72/100

Support responsiveness78/100

Licensing & trust57/100

What we like

Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
LegitScript verified
Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health

Where points come off

Legal entity name and state of incorporation not publicly disclosed
The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
Per-state availability not listed
$149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
FDA issued Kin Meds a warning letter in February 2026; the letter is public in FDA's warning-letter database

The bottom line — C

Best for: Compounded and brand-name GLP-1 plus a longevity stack on one platform.

Kin Meds ranks #203 of 542 providers scored — see #1, CoreAge Rx here.

FDAWarning letter issued to Kin Meds in February 2026. See the FDA warning-letter database.

Visit Kin Meds ↗

Pricing and verification reflect Kin Meds's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Kin Meds's site. Not medical advice; see our disclosure.

← Back to the ranking